NUVB Competitors & Alternatives
Compare Nuvation Bio Inc with similar stocks in the same industry
Biotechnology
NUVB
Main Stock$4.92
Tradestie Score
65
Market Cap
$1.27B
Revenue Growth
26.0%
Analyst Upside
+150.9%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$16.41
|
$1.74B | - | 62 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$31.53
|
$1.68B | - | 59 | Compare |
|
MNKD
Mannkind Corporation
|
$3.90
|
$1.65B | - | 64 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$34.97
|
$1.63B | - | 56 | Compare |
|
BHVN
Biohaven Ltd.
|
$11.90
|
$1.57B | - | 61 | Compare |
|
VCEL
Vericel Corporation
|
$38.15
|
$1.56B | 89.7 | 61 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$81.98
|
$1.55B | - | 54 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$34.08
|
$1.55B | 14.2 | 65 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$31.01
|
$1.55B | - | 64 | Compare |
|
NVAX
Novavax Inc
|
$9.19
|
$1.54B | - | 50 | Compare |
More NUVB Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry